Info
13F
Schedule 13D

Eventide Asset Management, Llc - Significant Ownership

Signature - Title: /s/ Peter J. Luiso - Peter J. Luiso, General Counsel
Location: Boston, MA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Eventide Asset Management, Llc.

Significant Ownership of Eventide Asset Management, Llc

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BBNX	Beta Bionics, Inc.	Common Stock	11.32%	$52.5M		4.86M		Eventide Asset Management, LLC	Jan 31, 2025
XMTR	Xometry, Inc.	Class A Common Stock, par value $0.000001 per share	6.72%	$78.4M		3.15M		Eventide Asset Management, LLC	Dec 31, 2024
	Inventiva S.A.	Ordinary Shares, nominal value Euro 0.01 per share	6.7%			10.1M		Eventide Asset Management, LLC	May 9, 2025
MIRM	Mirum Pharmaceuticals, Inc.	Common Stock, par value $0.0001 per share	5.43%	$108M		2.61M		Eventide Asset Management, LLC	Dec 31, 2024
EVH	Evolent Health, Inc.	Class A Common Stock, par value $0.01 per share	5.2%	$59.8M		6.08M		Eventide Asset Management, LLC	Mar 31, 2025
LXEO	Lexeo Therapeutics, Inc.	Common Stock, $0.0001 par value per share	3.73%	$4.54M		1.23M		Eventide Asset Management, LLC	Dec 31, 2024
NKTR	Nektar Therapeutics	Common Stock, $0.0001 par value	3.61%	$4.92M		6.65M		Eventide Asset Management, LLC	Dec 31, 2024
INZY	Inozyme Pharma, Inc.	Common Stock, par value $0.0001 per share	3.46%	$2.35M		2.22M		Eventide Asset Management, LLC	Dec 31, 2024
AURA	Aura Biosciences, Inc.	Common Stock, par value $0.00001 per share	0%	$0	-$22.5M	0	-100%	Eventide Asset Management, LLC	Mar 31, 2025
ZNTL	Zentalis Pharmaceuticals, Inc.	Common Stock, $0.001 par value per share	0%	$0	-$6.4M	0	-100%	Eventide Asset Management, LLC	Mar 31, 2025

Showing 1 to 10 of 10 entries

Schedules 13D/G Reported by Eventide Asset Management, Llc:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.